Keith Lamont Cummings, Chief Financial Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 40,296 shares at $11.20 ($451K) on 2025-01-17, disclosed to the SEC on 2025-01-22.
Scheduled sale ($451k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.20 | 20,148 | $226K | 50.0% |
| 2 | $11.20 | 20,148 | $226K | 50.0% |
| Total | $11.20 avg | 40,296 | $451K | 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $712K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $528K | — | Filing → |